Evidence map›Paper›PMID 39835089›Full record

ArticleFrontiers in medicine2024

A bibliometric analysis of optic atrophy from 2003 to 2023: research trends and hot spots.

Liyuan Wang, Tianyang Yu, Runze Wang, Lijuan Fu, Feixue Dong, Shuang Zhao, He Sun, Yang Gao

Abstract read
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liyuan Wang *School of Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Tianyang Yu *School of Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Runze WangDepartment of Rehabilitation Medicine, Qingdao Eighth People's Hospital, Harbin, China.
Lijuan FuSchool of Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Feixue DongSchool of Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Shuang ZhaoSchool of Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
He SunSchool of Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Yang GaoDepartment of Acupuncture, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Hospital), Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Optic atrophy (OA) is primarily caused by damage to the retinal pathway system, including widespread degeneration of retinal ganglion cells and axons, leading to visual impairment and blindness. Despite its clinical significance and diverse etiological factors, there is currently a lack of comprehensive bibliometric analyses exploring research trends and hotspots within this field. Method: This study retrieved relevant literature on OA published between 2003 and 2023 from the Web of Science Core Collection database. We conducted a bibliometric analysis using tools such as CiteSpace, VOSviewer, and SCImago Graphica to examine annual publication trends, co-occurrence patterns, collaborative networks among countries and institutions, and the evolution of research hotspots of OA. Results: A total of 5,274 publications were included in the bibliometric analysis, comprising 4,561 research articles and 713 review articles. The United States emerged as the leading country in OA research, followed by Germany and China. Over the past two decades, the primary research hotspots focused on "mitochondrial dysfunction," "hereditary optic neuropathy," "ocular hypertension" and "diagnostic techniques." Future research trends are likely to revolve around "molecular mechanisms" and "therapeutic targets." Conclusion: This bibliometric analysis provides an overview of research developments in OA over the past 20 years, highlighting the emphasis on the pathological basis of OA and advancements in diagnostic and therapeutic approaches. Future studies should continue to explore the molecular basis of mitochondrial dysfunction to identify potential gene therapy targets for treating OA.

Indexed as

bibliometric analysiscollaborative networkoptic atrophyresearch trendWeb of Science

Identifiers

PMID39835089
PMCPMC11743512

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.